STEPHEN HALBERG: Open Payments
NPI 1245877000 · WICHITA FALLS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$874 in 39 payments from 12 companies in 2025. Trend: 2023 $895 · 2024 $845 · 2025 $874
Food & beverage: $874
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $355 |
| Novo Nordisk Inc | 8 | $122 |
| Antares Pharma, Inc. | 6 | $104 |
| GlaxoSmithKline, LLC. | 4 | $74 |
| ABBVIE INC. | 3 | $56 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $50 |
| Phathom Pharmaceuticals, Inc. | 1 | $25 |
| Exact Sciences Corporation | 1 | $19 |
| Viatris Specialty LLC | 1 | $18 |
| Axsome Therapeutics, Inc. | 1 | $18 |
Products named: AIRSUPRA, XYOSTED, Wegovy, FARXIGA, TRELEGY ELLIPTA, Kerendia, QULIPTA, Ozempic.
Industry payments across TX — which companies pay providers there.
